NEW YORK & MENLO PARK, Calif.--(BUSINESS WIRE)--Aug. 9, 2005--New Leaf Venture Partners (NLV Partners) announced today that the company has closed a $310 million venture capital fund dedicated to healthcare technologies. The company will invest primarily in firms focused on clinical-stage biopharmaceutical products, early-stage medical devices, and molecular diagnostics.
